Registry of Local Recurrences After Breast-conserving Surgery
ConditionBreast Cancer Recurrent
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUniversidade do Porto
About this trial
The ReLoCC project is a prospective, multicenter, clinical study to register cases of local recurrence after breast-conserving surgery, in centers dedicated to the treatment of breast cancer, in Portugal and Spain.
The comparison of the results obtained will allow the optimization of the treatment, making it increasingly personalized.
Eligibility criteria
Qualifiers
Female patients
Age > 18 years
Patients who have previously undergone breast-conserving surgery as part of the treatment of invasive or non-invasive (in situ) breast cancer
and adjuvant breast RT: total (WBI) or partial (PBI)
Disqualifiers
Male
Age < 18 years
Stage 4 at diagnosis
Patients operated outside the participating Centers and for whom it is not possible to obtain complete information regarding the primary treatment
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Universidade do Porto
Lead sponsor
Centro Hospitalar De São João, E.P.E.
Collaborator
Source ClinicalTrials.gov